Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00222638Phase 4Completed
Phase 4, randomised, double-blind trial of influenza vaccine in influenza (2 arms), sponsored by University of Perugia. Primary endpoints: Variations in INR value and Variations in Warfarin weekly dosage. Started Oct 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00222638.